Comparison

THZ1 European Partner

Item no. TMO-T3664-5mg
Manufacturer TargetMol
CASRN 1604810-83-4
Amount 5 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Citations 1. Kwiatkowski N, et al. Nature. 2014 Jul 31;511(7511):616-20.;Nilson KA, et al. Mol Cell. 2015 Aug 20;59(4):576-87.;
Smiles CN(C)C\C=C\C(=O)Nc1ccc(cc1)C(=O)Nc1cccc(Nc2ncc(Cl)c(n2)-c2c[nH]c3ccccc23)c1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias THZ1 2HCl,CDK7 inhibitor
Shipping Condition Cool pack
Available
Manufacturer - Targets
CDK
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
566.05
Description
THZ1 (CDK7 inhibitor) is a selective covalent inhibitor of CDK7, exhibiting binding affinity to the cysteine residue located at the outer end of the classical kinase domain, thus conferring high selectivity for CDK7, with an IC50 of 3.2 nM.
Pathways
Cell Cycle/Checkpoint

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close